2 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Methylphenidate Hydrochloride: new trials by email Literature Review of Methylphenidate Hydrochloride trials Research Report on Methylphenidate Hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder Methylphenidate Hydrochloride - Conduct Disorder, Attention Defict Hyperactivity Disorder | Phase 1 / Phase 2 | Withdrawn | National Institute of Mental Health (NIMH) | 2014-09-04 | 2019-12-03 | |
| SPD544 High Strength Bioequivalence Study SPD544, Methylphenidate hydrochloride - ADHD | Phase 1 | Completed | Shire | 28 | 2010-08-27 | 2021-06-09 |
| Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate Methylphenidate, Fatigue Evaluations - Fatigue | Phase 1 | Completed | M.D. Anderson Cancer Center | 31 | 2002-08-01 | 2022-01-04 |
Attention Deficit Disorder with Hyperactivity (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Conduct Disorder (1) · Fatigue (1)
M.D. Anderson Cancer Center (1) · National Institute of Mental Health (NIMH) (1) · Shire (1)
United Kingdom (1) · United States (1)
Eduardo Bruera, MD (1) · James J Blair, Ph.D. (1)